l9n/ Connecticut

2021 Regular Session

Senate Bill 262

AN ACT REQUIRING MANUFACTURERS OF BRAND NAME PRESCRIPTION DRUGS TO PROVIDE SAMPLES OF SUCH DRUGS TO MANUFACTURERS OF GENERIC PRESCRIPTION DRUGS.

Did not become law. It stopped in the House of Representatives on May 27, 2021. The 2021 session has ended.

What it does

The synopsis the General Assembly published with the bill.

To promote competition in the prescription drug market by allowing developers of generic drugs and biosimilar products to obtain reference samples.

Sponsors

Who carried the bill in each chamber, and who signed on. Each name leads to the member's page.

In the Senate

1 co-sponsor

Martin M. Looney

Its course

January 22 to May 27, 2021, on one scale. In the top row each mark is a day something happened; taller marks are busier days.

Each committee stop sits inside its chamber.

Every action24 actions on 14 days

In the SenateJan 22 to May 26124 days

General Law CommitteeJan 22 to Feb 1625 days

Judiciary CommitteeApr 28 to May 35 days

Appropriations CommitteeMay 12 to May 175 days

In the House of RepresentativesMay 26 to May 27 · stopped1 day

Text

Each version as the General Assembly printed it.

l9n doesn't hold this bill's text yet.

What happened

In l9n's words, one line for each step. Every action as the General Assembly published it is below.

In the Senate Jan 22 – May 26

  1. Jan 22Introduced and sent to General Law Committee
  2. Jan 25Heard in General Law Committee
  3. Feb 16General Law Committee recommended it
  4. Apr 28Sent to Judiciary Committee
  5. May 3Judiciary Committee recommended it
  6. May 12Sent to Appropriations Committee
  7. May 17Appropriations Committee recommended it
  8. May 26Passed the Senate

In the House of Representatives May 27

  1. May 27Arrived in the House of Representatives
All 24 actions, as published
  1. Jan 22REF. TO JOINT COMM. ONBoth houses
  2. Jan 25PUBLIC HEARINGBoth houses
  3. Feb 16Joint FavorableBoth houses
  4. Feb 17FILED WITH LCOBoth houses
  5. Feb 26REFERRED TO OLR, OFABoth houses
  6. Mar 4RPTD. OUT OF LCOBoth houses
  7. Mar 4FAV. RPT., TAB. FOR CAL., SEN.Senate
  8. Mar 4SENATE CALENDAR NUMBERSenate
  9. Mar 4FILE NO.Both houses
  10. Apr 28REF. BY SEN. TO COMM. ONSenate
  11. May 3Joint FavorableBoth houses
  12. May 4FILED WITH LCOBoth houses
  13. May 4RPTD. OUT OF LCOBoth houses
  14. May 4NO NEW FILE BY COMM. ONBoth houses
  15. May 4FAV. RPT., TAB. FOR CAL., SEN.Senate
  16. May 12REF. BY SEN. TO COMM. ONSenate
  17. May 17Joint FavorableBoth houses
  18. May 18FILED WITH LCOBoth houses
  19. May 18RPTD. OUT OF LCOBoth houses
  20. May 18NO NEW FILE BY COMM. ONBoth houses
  21. May 18FAV. RPT., TAB. FOR CAL., SEN.Senate
  22. May 26SENATE PASSEDSenate
  23. May 27FAV. RPT., TABLED FOR HOUSE CALENDARHouse of Representatives
  24. May 27HOUSE CALENDAR NUMBERHouse of Representatives